NADH as a cancer medicine [article]

Michael D Forrest
2015 bioRxiv   pre-print
We propose that NADH will exert a specific kill action against some cancers. NADH is a natural metabolite. We envisage a low side effect profile and that NADH therapy will, additionally, combat the wastage and weakness of cancer patients, which can be the cause of death in some cases. Significantly, NADH can be administered orally and has already cleared clinical trials, all be it for other pathologies.
doi:10.1101/019307 fatcat:3lcjc7lb2rhcbmfdki6fsuz2jy